Exact Mass: 249.0402222
Exact Mass Matches: 249.0402222
Found 83 metabolites which its exact mass value is equals to given mass value 249.0402222
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Pyridoxine 5'-phosphate
Pyridoxine phosphate, also known as pyridoxine 5-phosphoric acid or pyridoxine 5-(dihydrogen phosphate), is a member of the class of compounds known as pyridoxine-5-phosphates. Pyridoxine-5-phosphates are pyridoxines that carry a phosphate group at the 5-position. Pyridoxine phosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Pyridoxine phosphate can be found primarily in blood. Within the cell, pyridoxine phosphate is primarily located in the cytoplasm (predicted from logP). Pyridoxine phosphate exists in all living species, ranging from bacteria to humans. In humans, pyridoxine phosphate is involved in the vitamin B6 metabolism. Pyridoxine phosphate is also involved in hypophosphatasia, which is a metabolic disorder. Moreover, pyridoxine phosphate is found to be associated with obesity. Pyridoxine 5-phosphate is a substrate for Pyridoxine-5-phosphate oxidase and Pyridoxal kinase.
Norepinephrine sulfate
Plasma norepinephrine sulfate increases after sympathetic nervous system activation by an exhausting incremental exercise test and remain elevated up to 2 h after exercise. (PMID: 8330610). Human platelets contribute to the formation of plasma norepinephrine sulfate by norepinephrine uptake, intraplatelet sulfoconjugation and release of norepinephrine sulfate. (PMID: 7968241). Higher concentrations of norepinephrine sulfate in portal venous than arterial plasma indicate substantial production of norepinephrine by mesenteric organs. (PMID: 8627312). Intravenously infused norepinephrine is sulfoconjugated in humans, indicating that a major part of NE is sulfoconjugated in blood or at sites easily accessible from blood. (PMID: 12020748). Plasma norepinephrine sulfate increases after sympathetic nervous system activation by an exhausting incremental exercise test and remain elevated up to 2 h after exercise. (PMID: 8330610)
S-[(3R,3As,6S,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] ethanethioate
Phaclofen
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists Phaclofen is a selective GABAB receptor antagonist. Phaclofen is a peripheral and central baclofen antagonist. Phaclofen maybe a potential compound in determining the physiological significance of central and peripheral bicuculline-insensitive receptors with which GABA and (-)-baclofen interact[1][2].
2-[(2S)-2-Amino-3-carboxypropanoyl]oxybutanedioic acid
2-Acetylamino-3,4-dihydro-4-oxopteridine-6-carboxylic acid
8-Hydroxy-4-methoxythiochinaldinsaeure-S-methylester
Phaclofen
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists Phaclofen is a selective GABAB receptor antagonist. Phaclofen is a peripheral and central baclofen antagonist. Phaclofen maybe a potential compound in determining the physiological significance of central and peripheral bicuculline-insensitive receptors with which GABA and (-)-baclofen interact[1][2].
3-amino-5-(4-methoxyphenyl)thiophene-2-carboxylic acid
methyl 2-(4-methoxyphenyl)-1,3-thiazole-5-carboxylate
1H-Pyrazole-3-carboxylicacid, 4,5-dihydro-1-(4-nitrophenyl)-5-oxo-
C10H7N3O5 (249.03856919999998)
methyl 3-amino-3-(4-chlorophenyl)propanoate hydrochloride
2-[2-(4-METHOXYPHENYL)-1,3-THIAZOL-4-YL]ACETIC ACID
2-Amino-5-chloro-2-fluorobenzophenone
C13H9ClFNO (249.03566659999998)
3-(METHYLTHIO)-1-PHENYL-1H-PYRAZOLE-4-CARBOTHIOAMIDE
2-CYCLOPROPYLAMINOMETHYL-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
(r)-3-amino-4-(4-chlorophenyl)butanoic acid hydrochloride
PCPA methyl ester hydrochloride
PCPA methyl ester hydrochloride (4-Chloro-DL-phenylalanine methyl ester hydrochloride), a reversible tryptophan hydroxylase inhibitor, is a serotonin (5-HT) synthesis inhibitor. PCPA methyl ester hydrochloride crosses the blood brain barrier and reduces 5-HT central availability[1][2].
6-AMINO-2-(4-CHLORO-PHENYL)-PYRIMIDINE-4-CARBOXYLIC ACID
2-(4-methoxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid
5-Methyl-1-[2-(methylsulfonyloxy)ethyl]-2-nitro-1H-imidazole
2-(4-hydroxy-phenyl)-thiazole-4-carboxylic acid ethyl ester
trimethyl-(2,3,4-trifluoro-5-nitrophenyl)silane
C9H10F3NO2Si (249.04328759999999)
ETHYL 4-HYDROXY-2-PHENYL-1,3-THIAZOLE-5-CARBOXYLATE
2-AMINO-4-CHLORO-2-FLUOROBENZOPHENONE
C13H9ClFNO (249.03566659999998)
4-Chloro-5-(5-methoxy-1,3-oxazol-2-yl)-1H-pyrrolo[2,3-b]pyridine
POLY(ACRYLONITRILE-CO-VINYLIDENE CHLORIDE-CO-METHYL METHACRYLATE)
3-CHLORO-2-[(4-METHYLPHENYL)THIO]ANILINE
C13H12ClNS (249.03789419999998)
(s)-3-amino-4-(4-chlorophenyl)butanoic acid hydrochloride
(S)-3-Amino-4-(2-chlorophenyl)butyric acid hydrochloride
2-(2-methyl-5-nitroimidazol-1-yl)ethyl methanesulfonate
(r)-3-amino-4-(2-chlorophenyl)butanoic acid hydrochloride
(s)-3-amino-4-(3-chlorophenyl)butanoic acid hydrochloride
2-methyl-4-(4-methoxy)phenyl thiazole-5-carboxylic acid
Benzenamine,4-[[(4-chlorophenyl)thio]methyl]-
C13H12ClNS (249.03789419999998)
(S)-3-(4-Fluoro-benzenesulfinyl)-pyrrolidine hydrochloride
4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
C13H12ClNS (249.03789419999998)